Gill Simba
- SEC CIK
- 0001180763
No open-market purchases or sales filed in the past year.
Current role at each company
- FHTX Foghorn Therapeutics Inc.Directoras of Jun 25, 2026
- SER Serina Therapeutics, Inc.Directoras of Feb 17, 2026
- EVLO Evelo Biosciences, Inc.President & CEOas of Nov 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gill Simba as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EVLO Evelo Biosciences, Inc.
President & CEO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2023 (view filing)8:31 PM ET | Nov 8 | Same day | Gill SimbaPresident & CEO | SSale | −172 | $0.33 | −$56.76 | −1.0%17.8K after | 10b5-1 |
| Sep 29, 2023 (view filing) | Sep 28 | 1 day | Gill SimbaPresident & CEO | SSale | −2.00K | $3.94 | −$7.86K | −10.6%16.8K after | 10b5-1 |
| Aug 9, 2023 (view filing) | Aug 8 | 1 day | Gill SimbaPresident & CEO | SSale | −342 | $9.51 | −$3.25K | −8.3%3.75K after | 10b5-1 |
| May 10, 2023 (view filing)9:31 PM ET | May 8 | 2 days | Gill SimbaPresident & CEO | SSale | −3.54K | $0.1255 | −$443.89 | −5.7%58.5K after | 10b5-1 |